Imperial College London
Alternate

Professor Toby Prevost

Faculty of Medicine, School of Public Health

Visiting Professor
 
 
 
//

Contact

 

a.prevost

 
 
//

Location

 

57Stadium HouseWhite City Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Pennington:2021:10.1007/s40273-021-01026-5,
author = {Pennington, B and Alshreef, A and Flight, L and Metry, A and Poku, E and Hykin, P and Sivaprasad, S and Prevost, AT and Vasconcelos, JC and Murphy, C and Kelly, J and Yang, Y and Lotery, A and Williams, M and Brazier, J},
doi = {10.1007/s40273-021-01026-5},
journal = {PHARMACOECONOMICS},
pages = {913--927},
title = {Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study},
url = {http://dx.doi.org/10.1007/s40273-021-01026-5},
volume = {39},
year = {2021}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Pennington,B
AU  - Alshreef,A
AU  - Flight,L
AU  - Metry,A
AU  - Poku,E
AU  - Hykin,P
AU  - Sivaprasad,S
AU  - Prevost,AT
AU  - Vasconcelos,JC
AU  - Murphy,C
AU  - Kelly,J
AU  - Yang,Y
AU  - Lotery,A
AU  - Williams,M
AU  - Brazier,J
DO  - 10.1007/s40273-021-01026-5
EP  - 927
PY  - 2021///
SN  - 1170-7690
SP  - 913
TI  - Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
T2  - PHARMACOECONOMICS
UR  - http://dx.doi.org/10.1007/s40273-021-01026-5
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000644265500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 39
ER  -
Download